The NIH funding process according to John Ioannidis: “Conformity” and “mediocrity”?
John Ioannidis published a paper that concluded that the NIH study section process prioritizes "safe" science and "conformity." Is he correct, or is this an exaggeration that uses a view of science that "brave mavericks" advance science far more rapidly than teams collaborating to make incremental progress?
Andrew Weil Flirts with Evidence Based Medicine
Andrew Weil, MD, pops up quite frequently on SBM, most recently in this entry by Harriet Hall, so I will not spend much space introducing him. An excellent biography and critique of Dr. Weil was written by Arnold Relman, former Editor of the New England Journal of Medicine. It is over a decade old, but contemporary to some of the events described...
What does a new drug cost? Part II: The productivity problem
A few weeks ago I reviewed Ben Goldacre’s new book, Bad Pharma, an examination of the pharmaceutical industry, and more broadly, of the way new drugs are discovered, developed and brought to market. As I have noted before, despite the very different health systems that exist around the world, we all rely on private, for-profit, pharmaceutical companies to supply drug products and...
Support Science-Based Medicine
Next month is the 5 year anniversary of Science-Based Medicine. We have published 1575 articles so far, with 72,400 comments. We are getting about 475,000 views per month, and SBM has attracted the attention of the mainstream media, government agencies, peer-reviewed journals, and even television and movie producers. Over the last five years we have endeavored to be a valuable resource for...
Fun With Statistics
Statistics is the essential foundation for science-based medicine. Unfortunately, it’s a confusing subject that invites errors and misunderstandings. We non-statisticians could all benefit from learning more about statistics as well as trying to get a better understanding of just how much we don’t know. Most of us are not going to read a statistics textbook, but the book Dicing with Death: Chance,...
Now that Burzynski has gotten off in 2012, Burzynski The Movie will spawn a sequel in 2013
About a year ago, I became interested in a physician named Stanislaw Burzynski who has been treating cancer with compounds that he calls “antineoplastons” for over three decades without, in my opinion, ever having ever produced any compelling evidence that antineoplastons have significant anticancer activity. Although I had been vaguely aware of Burzynski and his activities, it was the first time that...
Down the Virtual Rabbit Hole: Kangan water®
The interwebs are more than a series of tubes, it has the power of endless distraction and tangents, a series of clickable rabbit holes that can drag you deeper and deeper into the alternative universes that are parallel with our own. One moment you can be on Science Based Medicine, grounded on the terra firma of reality, and then with a click...
Oregon Naturopaths v. Evidence-Based Medicine
Like every state, Oregon is struggling with the unsustainable costs of taxpayer-funded health care programs. In an attempt to tame this beast, Oregon recently established a system of coordinated care organizations, or CCOs, to (as the name suggests) coordinate medical, mental health, and dental care for residents enrolled in Oregon Health Plan, the state’s Medicaid program. The new system requires supervision of...
Journal of Clinical Oncology editorial: “Compelling” evidence acupuncture “may be” effective for cancer related fatigue
Journal of Clinical Oncology (JCO) is a high impact journal (JIF > 16) that advertises itself as a “must read” for oncologists. Some cutting edge RCTs evaluating chemo and hormonal therapies have appeared there. But a past blog post gave dramatic examples of pseudoscience and plain nonsense to be found in JCO concerning psychoneuroimmunology (PNI) and, increasingly, integrative medicine and even integrations...
Homeopathic Vaccines Revisited
One of the core fictions of “complementary” or “integrative” medicine is that they are primarily offered in addition to science-based medicine and only to fill gaps in what SBM can offer. The original marketing label used to promote treatments that are not adequately supported by evidence , “alternative medicine,” was a bit more accurate in that at least it acknowledged that such...